Kazam Joshua A

Average Profitability
<0.0001%
Insider Buys Quantity
13
Insider Buys Sum
$709,953.44
Insider Sells Quantity
0
Insider Sells Sum
$0

Insider Activity of Kazam Joshua A

The largest purchase of all time was on 2009-07-07 and amounted to 197628 shares of Capricor Therapeutics, Inc. for $249,999.

Biography of Kazam Joshua A

No biography is available at this moment.

2022-01-12PurchaseAllogene Therapeutics, Inc.
ALLO
director
15,000
0.0108%
$12.60$189,000-18.73%
2019-03-05PurchaseTarget Hospitality Corp.
TH
director
5,000
0.0063%
$10.20$51,000-34.63%
2019-03-01PurchaseTarget Hospitality Corp.
TH
director
5,000
0.0063%
$10.13$50,650-33.58%
2019-01-22PurchaseTarget Hospitality Corp.
TH
director
20,000
<0.0001%
$0.00$62-14.79%
2015-01-21PurchaseCapricor Therapeutics, Inc.
CAPR
director
14,192
0.0871%
$3.52$49,998+21.63%
2012-03-30PurchaseCapricor Therapeutics, Inc.
CAPR
President & CEO
125,000
0.2518%
$0.40$50,000-78%
2010-04-22PurchaseCapricor Therapeutics, Inc.
CAPR
Chief Executive Officer
50,000
0.1527%
$0.70$35,000-18.31%
2009-07-07PurchaseCapricor Therapeutics, Inc.
CAPR
director
197,628
0.8278%
$1.26$249,999+8.77%
2009-03-12PurchaseCapricor Therapeutics, Inc.
CAPR
director
1,020
0.0049%
$0.75$765+100%
2008-12-16PurchaseCapricor Therapeutics, Inc.
CAPR
director
6,200
0.0281%
$1.15$7,130+28.57%
2008-12-15PurchaseCapricor Therapeutics, Inc.
CAPR
director
5,000
0.0181%
$1.05$5,250+12.5%
2008-12-12PurchaseCapricor Therapeutics, Inc.
CAPR
director
8,200
0.0576%
$1.44$11,815+57.06%
2008-12-11PurchaseCapricor Therapeutics, Inc.
CAPR
director
8,200
0.0427%
$1.13$9,284+47.78%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.